Corcept Therapeutics Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $68.52 High: $71.57
on July 2, 2025

52 Week Range

Low: $29.42 High: $117.33
on July 9, 2024
on March 31, 2025

All-Time High: $117.33 on March 31, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $7.6B
EPS i 1.15
P/E Ratio (TTM) i 62.07
Forward P/E i 40.79
P/B Ratio i 11.07
PEG Ratio i 40.79
Div. Yield i N/A
ROE i 21.77%
Beta i 0.182
Debt to Equity i 1.00

Financial Highlights

Profitability

Gross Margin i 98.47%
Operating Margin i 2.17%
Profit Margin i 19.55%

Returns and Earnings

Return on Assets (TTM) i 9.18%
Return on Equity (TTM) i 21.77%
EBITDA i $112.5M
Net Income (TTM) i $132.5M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i
Quarterly Revenue Growth i
Quarterly Earnings Growth i

Peer Performance Comparison

Company Market Cap 1W 1M 3M 6M YTD 1Y 3Y 5Y
Corcept Therapeutics CORT 7.57B Mid-cap -9.72% -3.31% -24.61% 38.70% 38.70% 144.02% 165.56% 344.85%
Vertex VRTX 114.06B Large-cap 0.42% 1.51% -6.72% 11.44% 11.44% -6.19% 51.28% 51.20%
Regeneron REGN 55.27B Large-cap 2.42% 8.99% -13.30% -25.21% -25.21% -49.24% -15.54% -15.44%
Blueprint Medicines BPMC 8.29B Mid-cap 0.06% 0.43% 49.34% 47.18% 47.18% 14.75% 126.55% 62.31%
Roivant Sciences ROIV 7.82B Mid-cap -5.20% -2.06% 11.07% -9.44% -9.44% 5.82% 132.85% 13.61%
Bio-Techne TECH 7.92B Mid-cap 4.16% 7.14% -9.19% -27.14% -27.14% -27.98% -44.37% -24.45%

Ownership & Short Interest

Insider Ownership i 11.49%
Institutional Ownership i 79.67%
Shares Short i 13M
Short Ratio i 10.65
Short % of Shares Outstanding i 16.06%
Average 10-Day Volume i 1M
Average 90-Day Volume i 1M

Corcept Therapeutics Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Corcept Therapeutics would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is CORT's 52-week high and low?

In the last 52 weeks, Corcept Therapeutics reached a high of $117.33 (on March 31, 2025) and a low of $29.42 (on July 9, 2024).

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.